Efficacy and Safety of Using Autologous Dendritic Cells Combined With Cytokine-Induced Killer Cells as an Adjuvant Therapy on Advanced Malignant Melanoma
Immunotherapy: Open Access
doi 10.4172/2471-9552.1000149
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
OMICS Publishing Group